Request that the FDA declare that the drug products Metformin HCl Capsules, 250 mg, 500 mg, and 625 mg, are suitable for consideration in an Abbreviated New Drug Application (ANDA)
🏛 Food and Drug Administration (FDA)FDA-2026-P-5991
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.